Table 2

Outcomes of the cost analyses for two groups of patients receiving adsorptive granulocyte and monocyte apheresis (GMA) or prednisolone (PSL) at the end of the study (average values are presented)
Factored item GMA PSL P value
Days of hospitalization 41.1 41.8 ns
(n=19) (n=17)
Hospitalization cost (euro)* 12739.4 8633.6 P<0.05
(n=19) (n=17)
Cumulative dose of PSL before the treatment (mg) 2457.9 3030.4 ns
(n=24) (n=17)
Concomitant dose of PSL during this study (mg) 0 (naïve) 1122.4 P<0.001
(n=24) (n=17)
Cumulative dose of PSL up to the end of study (mg) 2457.9 4152.8 P=0.28
(n=24) (n=17)
Adverse event (%)
Transient 12.5 11.8 ns
Non-transient 0 35.3 P<0.001

* Converted at 150 yen to the euro. Hospitalization cost includes treatment cost, medication, tests.

Tominaga et al.

Tominaga et al. BMC Gastroenterology 2013 13:41   doi:10.1186/1471-230X-13-41

Open Data